Abstract: Systems and methods for reaming bone can include an elongate body having a proximal end, a distal end, and an inner throughbore extending therebetween. An angled guide can be configured to engage the distal end of the elongate body and define a bearing surface at a predetermined angle relative to a centerline of the elongate body. A drive shaft can be configured to extend through the inner throughbore of the elongate body, the drive shaft having a distal end configured to extend beyond the distal end of the elongate body. A reamer head can be pivotably coupled to the distal end of the drive shaft, the reamer head having a distal-facing cutting surface configured to cut bone and a proximal-facing portion configured to bear against the bearing surface of the angled guide to orient the reamer head at the predetermined angle.

Abstract: The present invention relates to a chemical process for the manufacture of a compound of Formula II

Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.

Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-[(4-fluoro-2-methy-1-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline starting from a compound of Formula IX: wherein R4 is a protecting group; or an intermediate there between, using process steps, reagents and conditions as described.

Abstract: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.

Abstract: 2-Benzyloxyalkyl halophenones of the formula (3): wherein X1 and X2 are each independently H, Cl or F, provided that at least one of X1 and X2 is Cl or F; one of R3 and R4 is H and the other is optionally substituted benzyloxy; and R5 is an unsubstituted alkyl, preferably a C1-6 alkyl group. The compounds are useful as intermediates for preparing 2-hydroxyalkyl halophenones.

Abstract: A process is provided for the preparation of compounds of Formula (1): wherein X1 and X2 are each independently H, Cl or F, provided that at least one of X1 and X2 is Cl or F; one of R1 and R2 is H and the other is OH; and R5 is an unsubstituted alkyl, preferably a C1-6 alkyl, group.

Abstract: An enzymatic process for preparing amides of Formula I wherein X, E and * have the meanings defined in the specification. Chiral intermediates useful for preparing compound of Formula I and enzymatic processes for preparing such chiral intermediates are also described.

Abstract: A stereoselective method for making compounds of Formula VIII ##STR1## wherein A and * are as defined in the specification. Enzymic processes and intermediates useful for preparing compound of Formula VIII are disclosed.

Abstract: A process for purifying elemental phosphorus that contains antimony using an oxidizer, such as hydrogen peroxide, peroxymonosulfate, peroxydisulfate, or a hypochlorite, in a two phase system containing water and phosphorus as the two liquids. A purified elemental phosphorus having 200 ppb or less antimony content.

Abstract: A process for the separation of at least one isomer from a mixture of isomers of a tetrahydropyran-2-one, having at least two chiral centres which comprises selective reaction of at least one isomer with a reagent catalysed by a hydrolase enzyme whereby at least one isomer is preferentially converted into a distinct chemical species from the other isomers so that it is susceptible of separation by an appropriate chemical or physical separation process in which the tetrahydropyran-2-one is of Formula (1): ##STR1## wherein: Z is --H or a protecting group susceptible of reaction with the reagent under the influence of the enzyme; andY is formyl or protected formyl.

Abstract: A process for the separation of at least one isomer from a mixture of isomers of a tetrahydropyran-2-one, having at least two chiral centers which comprises selective reaction of at least one isomer with a reagent catalyzed by a hydrolase enzyme whereby at least one isomer is preferentially converted into a distinct chemical species from the other isomers so that it is susceptible of separation by an appropriate chemical or physical separation process in which the tetrahydropyran-2-one is of Formula (1): ##STR1## wherein: Z is --H or a protecting group susceptible of reaction with the reagent under the influence of the enzyme; andY is formyl or protected formyl.

Abstract: A process for the separation of at least one isomer from a mixture of isomers of a tetrahydropyran-2-one, having at least two chiral centers which comprises selective reaction of at least one isomer with a reagent catalyzed by a hydrolase enzyme whereby at least one isomer is preferentially converted into a distinct chemical species from the other isomers so that it is susceptible of separation by an appropriate chemical or physical separation process in which the tetrahydropyran-2-one is of Formula (1): ##STR1## wherein: Z is --H or a protecting group susceptible of reaction with the reagent under the influence of the enzyme; andY is formyl or protected formyl.

Abstract: A process for the separation of at least one isomer from a mixture of isomers of a tetrahydropyran-2-one, having at least two chiral centres, which comprises selective reaction of at least one isomer with a reagent catalysed by a hydrolase enzyme whereby at least one isomer is preferentially converted into a distinct chemical species from the other isomers so that it is susceptible of separation by an appropriate chemical or physical separation process in which the tetrahydropyranone is of Formula (1): ##STR1## wherein: Z is --H or a protecting group susceptible of reaction with the reagent under the influence of the enzyme; andY is optionally substituted hydrocarbyl.

Abstract: The invention is a novel composition of alkylated phenyl phosphate esters comprising by weight 1% to 20% trialkylphenyl phosphate, 10% to 50% dialkylphenyl monophenyl phosphate, 15% to 60% monoalkylphenyl diphenyl phosphate and less than 2% triphenyl phosphate and a process for preparing the composition comprising passing the composition at least once through a thin film evaporator at a temperature of about 200.degree. C. to about 250.degree. C. at a pressure sufficiently less than 5 kPa to evaporate about 5% to about 30% of the composition.

Abstract: A manufacturing process and composition is claimed for a composition of matter comprising sodium carbonate, sodium carbonate perhydrate, a fluorescent whitening agent and a diphosphonic acid. The process comprises incorporating the fluorescent whitening agent and diphosphonic acid into aqueous hydrogen peroxide, uniformly applying the hydrogen peroxide solution to particulate sodium carbonate to form a reaction mixture, urging water vapor from the surface of the reaction mixture and maintaining the temperature of the reaction mixture between about 35.degree. C. and 80.degree. C.

Abstract: A process is provided for making halogen-substituted triaryl phosphate esters which are normally solid under ambient conditions. The process comprises reacting a halogenated phenol with phosphorus oxychloride in the presence of a magnesium chloride catalyst above the melting point of the desired product. After the reaction is complete the product is recovered by adding an alcohol, such as, pentanol, 2-ethyl hexanol or hexanol and cooling the resulting mixture below the melting point of the product.

Abstract: An environmentally acceptable process is provided to synthesize a 2-(alkylbenzoyl)benzoic acid suitable for synthesizing a 2-alkylanthraquinone without further purification. Usually the crude product is isolated from the reaction mixture by a succession of steps which generate a large volume of aqueous waste. The present process eliminates or decreases these wastes and produces a product of sufficient purity for synthesizing as 2-alkylanthraquinone.

Abstract: 3-(2'-chloro-3',3',3'-trifluoropropenyl)-2,2-dimethylcyclopropane-1-carboxy lic acid esters are prepared by dehydrohalogenation of the corresponding 3-(2',2'-dichloro-3',3',3-trifluoropropyl) compounds by reaction with an alkali metal carbonate in a polar aprotic solvent. The products are intermediates in the preparation of pyrethroid insecticides or are themselves insecticides.

Abstract: A novel crystalline modification of an enantiomeric pair of isomers of the insecticide cyhalothrin having improved handling characteristics.